Thomas Patrick Kelly - Net Worth and Insider Trading
Thomas Patrick Kelly Net Worth
The estimated net worth of Thomas Patrick Kelly is at least $2 Million dollars as of 2024-11-13. Thomas Patrick Kelly is the CFO of Deciphera Pharmaceuticals Inc and owns about 66,085 shares of Deciphera Pharmaceuticals Inc (DCPH) stock worth over $2 Million. Details can be seen in Thomas Patrick Kelly's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Thomas Patrick Kelly has not made any transactions after 2024-01-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Thomas Patrick Kelly
Thomas Patrick Kelly Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Thomas Patrick Kelly owns 1 companies in total, including Deciphera Pharmaceuticals Inc (DCPH) .
Click here to see the complete history of Thomas Patrick Kelly’s form 4 insider trades.
Insider Ownership Summary of Thomas Patrick Kelly
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DCPH | Deciphera Pharmaceuticals Inc | 2024-01-16 | Chief Financial Officer |
Thomas Patrick Kelly Latest Holdings Summary
Thomas Patrick Kelly currently owns a total of 1 stock. Thomas Patrick Kelly owns 66,085 shares of Deciphera Pharmaceuticals Inc (DCPH) as of January 16, 2024, with a value of $2 Million.
Latest Holdings of Thomas Patrick Kelly
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DCPH | Deciphera Pharmaceuticals Inc | 2024-01-16 | 66,085 | 25.59 | 1,691,115 |
Holding Weightings of Thomas Patrick Kelly
Thomas Patrick Kelly Form 4 Trading Tracker
According to the SEC Form 4 filings, Thomas Patrick Kelly has made a total of 13 transactions in Deciphera Pharmaceuticals Inc (DCPH) over the past 5 years, including 0 buys and 13 sells. The most-recent trade in Deciphera Pharmaceuticals Inc is the sale of 2,435 shares on January 16, 2024, which brought Thomas Patrick Kelly around $35,234.
Insider Trading History of Thomas Patrick Kelly
- 1
Thomas Patrick Kelly Trading Performance
Thomas Patrick Kelly Ownership Network
Ownership Network List of Thomas Patrick Kelly
Ownership Network Relation of Thomas Patrick Kelly
Thomas Patrick Kelly Owned Company Details
What does Deciphera Pharmaceuticals Inc do?
Who are the key executives at Deciphera Pharmaceuticals Inc?
Thomas Patrick Kelly is the Chief Financial Officer of Deciphera Pharmaceuticals Inc. Other key executives at Deciphera Pharmaceuticals Inc include EVP & Chief Medical Officer Matthew L Sherman , Chief Commercial Officer Daniel C. Martin , and SVP & Regulatory & Quality Jama Pitman .
Deciphera Pharmaceuticals Inc (DCPH) Insider Trades Summary
Over the past 18 months, Thomas Patrick Kelly made 4 insider transaction in Deciphera Pharmaceuticals Inc (DCPH) with a net sale of 9,198. Other recent insider transactions involving Deciphera Pharmaceuticals Inc (DCPH) include a net sale of 23,797 shares made by Daniel C. Martin , a net sale of 12,184 shares made by Matthew L Sherman , and a net sale of 5,931 shares made by Jama Pitman .
In summary, during the past 3 months, insiders sold 0 shares of Deciphera Pharmaceuticals Inc (DCPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 105,002 shares of Deciphera Pharmaceuticals Inc (DCPH) were sold and 10,000 shares were bought by its insiders, resulting in a net sale of 95,002 shares.
Deciphera Pharmaceuticals Inc (DCPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Deciphera Pharmaceuticals Inc Insider Transactions
Thomas Patrick Kelly Mailing Address
Above is the net worth, insider trading, and ownership report for Thomas Patrick Kelly. You might contact Thomas Patrick Kelly via mailing address: C/o Deciphera Pharmaceuticals, Inc., 200 Smith Street, Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
